511549-93-2

Upstream product

• 511549-91-0 tert-Butyl-dimethyl-((1S,5R)-spiro[4.4]non-6-en-1-yloxy)-silane 
• 65-85-0 benzoic acid 
• 511549-92-1 (2S,5R,6S)-6-(tert-Butyl-dimethyl-silanyloxy)-spiro[4.4]nonan-2-ol 

Downstream Products

• 511549-97-6 3-benzoyl-1-[6-(tert-butyl-dimethyl-silanyloxy)-spiro[4.4]non-2-yl]-5-methyl-1H-pyrimidine-2,4-dione 
• 511549-95-4 N-{1-[6-(tert-butyl-dimethyl-silanyloxy)-spiro[4.4]non-2-yl]-2-oxo-1,2-dihydro-pyrimidin-4-yl}-benzamide 
• 511549-98-7 3-Benzoyl-1-((2S,5R,6S)-6-hydroxy-spiro[4.4]non-2-yl)-5-methyl-1H-pyrimidine-2,4-dione 
• 511549-96-5 N-[1-((2S,5R,6S)-6-Hydroxy-spiro[4.4]non-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-benzamide 

Relevant academic research and scientific papers

Practical synthesis of enantiopure spiro[4.4]nonane C-(2′-deoxy) ribonucleosides

(Chemical Equation Presented) The levorotatory diol 7 has been sequentially monosilylated, dehydrated, and oxidized at the allylic methylene group to provide (+)-12. The enantiomeric dextrorotatory diol 7 has been directed down a different sequence of ste

Conversion of the enantiomers of spiro[4.4]nonane-1,6-diol into both epimeric carbaspironucleosides having natural C1′ absolute configuration

(Matrix presented) The enantiomers of spiro[4.4]nonane-1,6-diol have been transformed by different reaction pathways into the two possible carbaspironucleoside epimers with natural C1′ absolute stereochemistry.